Trial Profile
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Cancer
- Focus Therapeutic Use
- 27 Feb 2017 Status changed from recruiting to completed.
- 10 Sep 2008 New trial record.